yep, the market has overlooked Matt's talents at claiming discoveries he had no leadership of, and have rated the company a sub $10M joke. I wonder how much patience R&T have left?
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025